Drugs / Aramchol free acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT06502561 Comparator | Feb → Jun 2025 | — | Galmed Pharmaceuticals Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aramchol free acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06502561 ↗ |
| Route | Oral | “a 300 mg tablet of Aramchol free acid (AA; Reference) in the other period” NCT06502561 ↗ |